The main medical markets for sealants, glues, hemostasis and anti-adhesion in Latin America are Brazil and Mexico, followed by Argentina.
Brazil, despite its size (population 196 million), is not a lucrative medical market because of the wide economic disparity between the wealthy and poor segments of the population. The state-run Unified Health System (SUS) covers 75% of the population but only 42% of total health care expenditure is in the public sector. Private health care covers 17.5 million subscribers, less than 10% of the population. Thus conventional, low-cost closures (sutures, staples, tapes) dominate the market and more expensive novel closures (sealants and glues) have relatively modest market shares. The same is true of Argentina, which is still recovering from a severe economic depression in the 1990s. Mexico, the eighth biggest trading market in the world, operates a health care system under which 60%–70% of the population are covered by public insurance schemes. In terms of expenditure on medical products, Mexico occupies a position between that of developed and developing economies, and this is reflected in the shares of the wound closure market represented by premium-priced and commodity product groups.
Below is illustrated the segmentation of the sealants, glues, hemostasis and anti-adhesion products market in the major countries of Latin America. As is evident from the graphic, glues and sealants have gained a significant share of the sutures and staples market. How much more share glues and sealants can gain is dependent upon caseload conversion with existing products, new products developed and, to a significant degree, penetration of the sutures and staples markets by products from major manufacturers whose distribution capabilities are establ
Source: MedMarket Diligence, LLC; Report #S175